Novavax (NVAX) Property, Plant & Equipment (Net) (2010 - 2026)

Novavax (NVAX) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 642,333.36
2 Nanobiotix 1,911.83 Bn 1,911.77 Bn - 5.32 Mn
3 Akari Therapeutics 959.56 Bn 959.56 Bn - -
4 BeOne Medicines 471.57 Bn 466.77 Bn 1.35 Bn 1.64 Bn
5 Vertex Pharmaceuticals 122.01 Bn 114.76 Bn 2.59 Bn 1.61 Bn
6 Regeneron Pharmaceuticals 70.09 Bn 61.34 Bn 3.31 Bn 5.27 Bn
7 Belite Bio 62.68 Bn 62.68 Bn - -
8 Argenx Se 55.86 Bn 50.68 Bn 1.41 Bn 1.96 Bn
9 Alnylam Pharmaceuticals 37.48 Bn 34.47 Bn 959.66 Mn 518.26 Mn
10 Novavax 1.24 Bn 453.01 Mn 108.82 Mn 42.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 42.15 Mn
Mar 31, 2026 42.15 Mn
Dec 31, 2025 44.80 Mn
Dec 31, 2025 44.80 Mn
Sep 30, 2025 49.12 Mn
Sep 30, 2025 49.12 Mn
Jun 30, 2025 129.64 Mn
Jun 30, 2025 129.64 Mn
Mar 31, 2025 133.54 Mn
Mar 31, 2025 133.54 Mn
Dec 31, 2024 138.41 Mn
Dec 31, 2024 138.41 Mn
Sep 30, 2024 285.72 Mn
Sep 30, 2024 285.72 Mn
Jun 30, 2024 288.56 Mn
Jun 30, 2024 288.56 Mn
Mar 31, 2024 291.09 Mn
Mar 31, 2024 291.09 Mn
Dec 31, 2023 305.77 Mn
Dec 31, 2023 305.77 Mn